mRNA cancer vaccine reprograms immune system to tackle glioblastoma.

“The demonstration that making an mRNA cancer vaccine in this fashion generates similar and strong responses across mice, pet dogs that have developed cancer spontaneously, and human patients with brain cancer is a really important finding, because oftentimes we don’t know how well the preclinical studies in animals are going to translate into similar responses in patients.” The next step after this 4-person trial is a 24-person trial. Balancing safety vs quick deployment of this miraculous cure seems like a tough choice. ~ learn more